Genetic analysis of multiple sclerosis.

被引:31
|
作者
Compston A. [1 ]
Sawcer S. [1 ]
机构
[1] University of Cambridge Neurology Unit, Addenbrooke's Hospital, Hills Road
关键词
Multiple Sclerosis; Linkage Disequilibrium; Major Histocompatibility Complex; Human Leukocyte Antigen; Human Leukocyte Antigen Class;
D O I
10.1007/s11910-002-0085-3
中图分类号
学科分类号
摘要
The increased recurrence risk within families indicates a role for genetic factors in the etiology of multiple sclerosis. Genes may influence susceptibility to the development of multiple sclerosis and the subsequent course of the disease. To date, associations have only been demonstrated consistently with class II major histocompatibility complex (MHC) alleles. The relatively low yield from additional candidate gene studies is only modestly advanced by several whole-genome linkage analyses, and by the first in a series of planned whole-genome linkage disequilibrium screens for allelic associations. The aims of linkage and association are to narrow the search for chromosomal regions encoding genes for multiple sclerosis and, with information from the human gene project, suggest new positional candidates. In time, it is expected that these genes will include some that confer susceptibility to the general process of autoimmunity, others that are specific for multiple sclerosis in all populations, some that act only in defined ethic groups, and those that determine particular phenotypes or shape the clinical course. These genetic analyses are predicated on the assumption that multiple sclerosis is one disease; a major part of future studies will be to resolve the question of disease heterogeneity in multiple sclerosis. When eventually in place, the potential of this genetic knowledge for improved understanding of the pathogenesis of multiple sclerosis and designing novel treatments is considerable.
引用
收藏
页码:259 / 266
页数:7
相关论文
共 50 条
  • [31] Intravenous immunoglobulin in the treatment of intermittent multiple sclerosis. An update
    Fazekas, F
    Strasser-Fuchs, S
    Hartung, HP
    NERVENARZT, 1998, 69 (04): : 361 - 365
  • [32] Contribution of ecological evaluation of executive disorders in multiple sclerosis.
    Rouaud, O.
    Graule-Petot, A.
    Couvreur, G.
    Contegal, F.
    Osseby, G. V.
    Benatru, I.
    Giroud, M.
    Moreau, T.
    REVUE NEUROLOGIQUE, 2006, 162 (10) : 964 - 969
  • [33] Therapeutic strategies in multiple sclerosis. I. Immunotherapy
    Hohlfeld, R
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1999, 354 (1390) : 1697 - 1710
  • [34] Immunologic therapy for secondary and primary progressive multiple sclerosis.
    Myers L.W.
    Current Neurology and Neuroscience Reports, 2001, 1 (3) : 286 - 293
  • [35] Mexican Consensus for Multiple Sclerosis. Diagnostic and therapeutic guide
    Carlos, Cuevas
    Quintana Merced, Velazquez
    Lilia, Nunez
    Eli, Skromne
    Raul, Arcega
    Noe, Barroso
    Alberto, Cabanas
    Hector, Colorado
    Guillermo, Davila
    Manuel, De la Maza
    Eduardo, Duriez
    Felipe, Garcia
    Victor, Gonzalez
    Rafael, Juarez
    Jaime, Laventman-Grinberg
    Alberto, Lifshitz
    Elizondo David, Lozano
    Juan, Lozano
    Jose Alberto, Perez Zuno
    Mireya, Rodriguez
    Flores Ignacio, Rojas
    REVISTA MEXICANA DE NEUROCIENCIA, 2007, 8 (02): : 155 - 162
  • [36] Role of T-regulatory cells in multiple sclerosis.
    Ignacio Rojas, Juan
    Gonzalez, Sergio J.
    Patrucco, Liliana
    Cristiano, Edgardo
    MEDICINA-BUENOS AIRES, 2010, 70 (01) : 79 - 86
  • [37] Management of spasticity, pain, and paroxysmal phenomena in multiple sclerosis.
    Schapiro R.T.
    Current Neurology and Neuroscience Reports, 2001, 1 (3) : 299 - 302
  • [38] Interferon β for multiple sclerosis. How much is good enough?
    Warnke, C.
    Leussink, V. I.
    Kieseier, B. C.
    Hartung, H. -P.
    NERVENARZT, 2010, 81 (12): : 1476 - +
  • [39] Immunologic therapy for relapsing-remitting multiple sclerosis.
    MacLean H.J.
    Freedman M.S.
    Current Neurology and Neuroscience Reports, 2001, 1 (3) : 277 - 285
  • [40] Depression and anxiety in multiple sclerosis. Review of a fatal combination
    Jellinger, Kurt A.
    JOURNAL OF NEURAL TRANSMISSION, 2024, 131 (08) : 847 - 869